ASME
Biofabrication, Biomanufacturing, Biopharmaceutical, COVID-19, Supply Chain

Some of the images from the first weeks of the COVID-19 pandemic are indelible: doctors and nurses wearing garbage bags instead of gowns and reusing the same protective mask for days at a time; homemade plastic face shields replacing professional-grade models; live coverage of deliveries of personal protective equipment to hard-hit hospitals. The...

SME
Biopharmaceutical, COVID-19, Manufacturing

Perhaps the biggest achievement thus far at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has been disabusing companies that are members of the Manufacturing USA innovation institute that it is smart to be “a fast second” to market.

“Nobody actually believed when we started, except apparently us naively, that...

Genetic Engineering & Biotechnology News
Biopharmaceutical, COVID-19, Innovation

In February 2020, NIIMBL ran a three-day workshop, which included participants from the FDA, the U.S. National Institute of Standards and Technology, plus what Erickson describes as “distinguished leaders in manufacturing and process development from 14 major manufacturers and suppliers.”

In January 2021, a team of pharmaceutical experts...

HuffPost
Biopharmaceutical, COVID-19

As of the end of April, the World Health Organization was tracking 71 coronavirus vaccines in preclinical trials, with five additional candidates already in clinical trials. Given how recently the COVID-19 pandemic began spreading, it might seem promising that there’s already a lot of activity on the immunization front.

With so many potential...